New Therapeutic Strategies in Nephrology

Glomerulonephritis

1. Front Matter

   Pages 1-1

   PDF

2. Modulation of Endothelial Barrier and Coagulant Properties by Hypoxia

   • S. Ogawa, M. Matsumoto, C. Esposito, D. Stern

   Pages 3-7

3. Cellular Immunity in Glomerular Pathology Primarily Induced by Immune-Complexes

   • Camussi G., Montrucchio G., Biancone L., Tetta C.

   Pages 8-18

4. Immunosuppressive Treatment of Autoimmune Nephropathies

   • E. Bartoli, R. Faedda, A. Satta

   Pages 19-24

5. Effect of Proteinase Inhibitor Camostat Mesilate on Nephrotic Syndrome

   • Hirofumi Makino, Toshinori Haramoto, Tsuneto Onbe, Isao Kumagai, Kazuharu Murakami, Toshio Ogura et al.

   Pages 25-27

6. Treatment of Nephrotic Hyperlipidemia

   • M. Elisaf, M. Dardamanis, G. Sferopoulos, M. Pappas, C. Korakis, K. C. Siamopoulos

   Pages 28-30

7. Effect of PSK Administration Followed by Initial Prednisolone Therapy in the Steroid Responsive Idiopathic Nephrotic Children

   • M. Hayashi, S. Okubo, K. Sakai

   Pages 31-33

8. Zinc Therapy for Minimal Change Nephrotic Syndrome and its Effect on IgG Synthesis

   • S. Okubo, S. Tomizawa, T. Gomi, M. Hayasi, K. Sakai

   Pages 34-36

9. The Nephrotic Syndrome in the Elderly: Epidemiological Data

   • V. Autuly, P. Simon, G. Cam, K. S. Ang, M. P. Ramee

   Pages 37-39

10. Antiaggregating Platelet Therapy in Chronic Glomerulone Phritis (GN)

    • Loschiavo C., Rugiu C., Ortalda V., Maschio G.

    Pages 40-42

11. Membranoproliferative Glomerulonephritis Type I: A Correlation Between Treated (138) and Untreated (108) Patients

    • F. Ferrario

    Pages 43-45

12. Methylprednisolone (MP) Pulse Therapy in Childhood IgA Nephropathy

    • Byoung-Soo Cho, Ji-Ho Song, Sung-Ho Cha, Chang-Il Ahn

    Pages 46-48

13. Immunosuppressive Treatment of Berger’s Disease

    • Faedda R., Manca M. L., Satta A., Palomba D., Bartoli E.

    Pages 49-51

14. High Dose Intravenous Human IgG in the Treatment of Idiopathic Membranous Nephropathy: Preliminary Report of a Multicentric Trial

    • Palla R., Cirami C., Panichi V., Bianchi A. M., Barsotti G., Cupisti A. et al.

    Pages 52-53

15. Treatment of Patients with Membranous Nephropathy(MN)

    • M. Polenaković, L. Grčevska

    Pages 54-56

16. Anticoagulant Therapy and Steroid Pulse Therapy to Rapidly Progressive IgA Nephropathy

    • Kenichi Shikata, Hirofumi Makino, Yoshikazu Hayashi, Toshinori Haramoto, Zensuke Ota

    Pages 57-59

17. Contemporary Treatment of Idiopathic Membranous Glomerulonephritis

    • I. Tishkov, D. Nikolov

    Pages 60-62

18. Effect of Methylprednisolone Pulse Therapy in Patients with Lupus Nephritis Assessed by who Morphologic Classification

    • Y. Yamasaki, H. Makino, Y. Hayashi, T. Haramoto, K. Sikata, I. Kumagai et al.

    Pages 63-65

19. Effect of Dilazep Dihydrochloride(DZ) Therapy in Patients with Chronic Glomerulonephritis

    • Y. Nagake, T. Ogura, H. Marino, Y. Yamasaki, K. Shikata, Z. Ota

    Pages 66-68